The ontogeny of the human immune system was studied by analyzing fetal and adult tissues for the presence of various lymphocytes populations and activation/maturation markers. CD95 (fas) was expressed in hematopoietic tissues during the final stages of development of monocytes, granulocytes, NK cells and T cells, but to a much lesser extent on B cells. In the periphery, CD95 expression declined on granulocytes and NK cells. CD95 was expressed at a higher level on CD45RA þ peripheral T-cells in the fetus than in the adult. Contrary to the belief that most fetal T-cells are naïve or resting, a notable number of CD45RO þ Tcells were observed as well as an unique CD95 2 CD45RO þ population. Activation markers CD25, CD122, CD69 and CD80
Ontogenic changes in CD95 expression on human leukocytes: prevalence of T-cells expressing activation markers and identification of CD95 2 CD45RO þ T-cells in the fetus 
Introduction
The human fetus is protected from most pathogens within the sterile environment of the uterus. Nonetheless, the cellular immune system begins its development early in gestation around the end of the first trimester. Reports suggest that T cells can be found in liver and peripheral blood as early as 7 and 9 weeks' gestation, respectively, although their overall numbers are very low [1, 2] . Intrathymic CD3
þ T-cells can be readily identified at the 8th week of gestation [3, 4] 
thymus is not anatomically completely mature until the 15th week of gestation [5] . Around this time, single positive (SP) CD4 þ CD8 2 CD3 þ and
þ T cells begin to accumulate more rapidly in the periphery [4] . The purpose for the early development of lymphocytes is not known but may simply reflect the necessity for Tlymphopoiesis to keep pace with overall fetal development to assure the generation and proper selection of sufficient numbers of lymphocytes before birth. Moreover, the early development of T cells may also serve to protect the fetus from in utero infections or engraftment by maternal lymphocytes. Determining the functional capacity of fetal lymphocytes is key to defining a role for these cells in fetal immunity. A limited number of studies have addressed the functional development of T cells from pre-term fetuses. Proliferation in response to allostimulation has been observed from fetal liver T-cells as young as 9 weeks' gestation [1,6 -8] . However, cultured fetal T-cells showed some defects in cytotoxic responses which could be reversed by prestimulation with cytokine [7, 9] . More on the functional capacity of fetal T-cells has been learned from analyses of T cells obtained from umbilical cord blood (UCB) at the time of birth. The T-cell repertoire appears fully formed at birth yet the repertoire appears to be composed of primarily naïve T-cells [10] . Whereas CD45RO þ CD45RA 2 memory T-cells are common in adult blood, UCB is primarily composed of CD45RO 2 CD45RA þ naive T-cells [11 -15] . Other cell-surface markers important in the functioning of T cells, such as CD3 and CD28, are expressed at similar levels to adult cells, but signaling through these proteins is attenuated in UCB T-cells. Neonatal Tcells failed to increase CD25, CD154 and CD178 (Fas ligand) expression when stimulated through CD3 and CD28 [16] . Reduced proliferative responses of allostimulated UCB T-cells have also been noted [11,17 -19] . Cord blood T-cells also have greatly reduced perforin expression [20] . Together with the observations of reduced CD178 expression, these findings suggest a reduced cytolytic capacity of neonatal T-cells similar to the findings on midgestation T-cells. Thus, despite T-lymphopoiesis beginning early in fetal life, some attenuation of T-cell function appears to occur in addition to the naïveté of the fetal immune system. CD95 (fas) is an important regulator of homeostasis of the immune system. CD95 is expressed on some T cells and to varying degrees on all other leukocyte lineages. Its expression is increased with T-cell activation and CD95 expression is highest on CD45RO
þ T-cells [21] . Triggering of programmed cell death by CD95 activation, through interaction with CD178, leads to clearance of activated T-cells and thereby limits immune responses [22, 23] . Neonatal T-cells express less CD95 than their adult counterparts [21, 24] . Expression of CD95 is also low to negative on SP thymic cells from midgestation thymic tissues, although CD95 is expressed on immature T-cell progenitors [25] . Moreover, the expression of CD95 on T cells has been shown to increase with age up to 75 years, after which expression decreases somewhat [26] . These data suggest that CD95 expression increases with the maturation of the immune system. In this regard it is worth noting that CD95 expression can increase more rapidly in children infected by the human immunodeficiency virus [24] .
In this study, it was our aim to gain a better understanding of the functional maturity of the fetal immune system by analyzing the expression of various cell surface markers on fetal T-cells as well as on other leukocyte populations. Expression of CD95 was analyzed on leukocytes harvested from peripheral blood, spleen, liver and bone marrow of midgestation fetuses and compared to CD95 expression on cells harvested from neonatal and adult tissues. Furthermore, various cell-surface markers, associated with activation, were analyzed on fetal, neonatal and adult T-cells. Our results suggest a higher level of T-cell activation in utero than would be predicted from previous studies of UCB T-cells. Adult peripheral blood was obtained by venipuncture. Approximately 7 ml of blood was drawn into a vacutainer tube containing ethylene diamine tetraacetic acid (EDTA). The blood was diluted to a total volume of 50 ml in PBS/BSA washing buffer consisting of phosphate buffered saline (PBS) containing 0.3% fraction-V ethanol-extracted bovine serum albumin (BSA) (Roche Applied Science, Indianapolis, IN) and 50 mg/ml gentamicin sulfate (Life Technologies, Grand Island, NY). The cells were pelleted by centrifugation and erythrocytes were depleted by chemical lyses using ACK lyses buffer, pH 7.2-7.4, consisting of 0.15 M NH 4 Cl, 1.0 mM KHCO 3 and 0.1 mM Na 2 EDTA (Sigma Chemical Company, St Louis, MO). The cells were pelleted by a 7-min centrifugation approximately 1 min after the addition of the ACK lyses buffer. If lysis of the erythrocytes was incomplete, the procedure was repeated. Otherwise the cells were washed once in PBS/BSA and suspended in blocking buffer consisting of PBS with 5% normal mouse serum (Gemini BioProducts, Inc., Woodland, CA) and 0.01% NaN 3 . Alternatively, peripheral blood mononuclear cells (PBMC) were prepared by centrifugation of the blood at 600 £ g for 25 min on a layer of 1.077 g/ml LymphoPrep (Life Technologies). The light-density cells were harvested and washed twice before being suspended in blocking buffer for staining.
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PBMC were isolated from neonatal UCB by immunomagnetic bead depletion of CD235a þ erythrocytes, performed as previously described for fetal liver cells [27] , and density separation using 1.077 g/ml Nycoprep (Life Technologies). The isolation of light-density neonatal blood cells was performed in an analogous fashion to the procedure described for the adult PBMC. In some cases, freshly prepared PBMC from UCB were frozen in autologous plasma with 10% dimethyl sulfoxide (Sigma Chemical Co.) and were thawed shortly before phenotypic analysis.
Fetal blood leukocytes were harvested from umbilical cords, placental vessels and/or hearts obtained from elective abortions. Blood was harvested from the cords after first washing the cords with PBS/BSA and then resecting (0.5 cm) the ends with scissors. The washed cords were placed in on a clean culture dish and were cut in 2 cm pieces. Fifteen to forty millilitres of PBS/BSA were injected with a 28-gage insulin syringe (Becton Dickinson & Co., Franklin Lakes, NJ) into the three cord vessels to rinse the blood out of the vessels through the fresh cut surface. In some initial experiments, fetal UCB was squeezed out through the fresh cut end using forceps. Blood samples were filtered using 70 m nylon-mesh cell strainers (BD Biosciences, San Jose, CA) as needed to remove clots or large cellular debris. For some fetal specimens fetal blood was obtained from the placenta by direct venopuncture of surface vessels near the placenta -umbilical cord junction. Placental blood was drawn into a syringe containing heparin. Fetal hearts were collected with the pericardial sack. The surface was cleaned with PBS/BSA to remove any contaminating maternal cells. The pericardial sack was then removed and the ends of the great vessels resected. In a clean dish, the heart was cut open from the great vessels down to the apex and the blood was rinsed out of the great vessels and chambers with PBS/BSA. Erythrocytes were depleted by chemical lysis using ACK lysis buffer or immunomagnetic bead depletion of CD235a þ cells [27, 28] . For some analyses of lymphocytes only, fetal PBMC were prepared using LymphoPrep as described above. Blood cells were washed and suspended in blocking buffer for staining.
Splenocytes were isolated by crushing the spleen with a glass pestle through a wire mesh cell strainer 
nylon-mesh cell strainer and pelleted by centrifugation. Erythrocytes were depleted by chemical lysis using ACK lysis buffer or immunomagnetic bead depletion of CD235a þ cells [27] . Alternatively, lightdensity splenocytes, depleted of erythrocytes and granulocytes, were isolated by centrifugation using LymphoPrep as described above. After either method, splenocytes were washed and suspended in blocking buffer for staining.
Fetal thymocytes were prepared for analysis by passage of the thymus through a cell strainer as described for the spleen samples. In order to remove erythrocytes and cellular debris, light-density thymocytes were harvested after centrifugation over a layer of 1.077 g/ml Nycoprep, as described above for the adult blood samples.
Light-density CD235a 2 fetal liver cells and fetal bone marrow cells were prepared by immunomagnetic-bead depletion and centrifugation over a layer of 1.077 g/ml Nycoprep as previously described [27] . 
Monoclonal antibodies
Flow cytometric analysis of cell surface markers
Approximately 2 £ 10 5 cells suspended in up to 200 ml blocking buffer were incubated in 96-well Costar V-bottom Plate (Corning Inc., Corning, NY) with saturating amounts of mAbs on ice for at least 30 min. Cells were washed twice with 250 ml PBS/BSA containing 0.01% NaN 3 (Sigma Chemical Co.). The washed cells were suspended in PBS/BSA containing 0.01% NaN 3 and 2 mg/ml propidium iodide (PI), purchased from Sigma Chemical Co. PI was used to mark dead cells, so that they could be excluded from the analysis. PI was omitted in 3-color analyses using PC5 or PerCP labeled mAbs. Flow cytometric analysis was performed using either a FACScan or a FACSCalibur flow cytometer (BD Biosciences). Analyses of results were performed using CellQuest software (BD Biosciences).
Data presentation and statistical analysis
The median results of multiple measurements done on individual tissue samples are reported to reduce the effects of outliers. Box plots are used to present the data, which show the 10th (lower bar), 25th (box bottom), 50th (median-bar in box), 75th (box top) and 90th (upper bar) percentiles. Circles in the box plots indicate outlying data points below the 10th and above the 90th percentiles. The significance of differences observed between fetal and adult cells was determined using an unpaired Student's t-test. Results were considered significant when P # 0:05: 
Analysis of CD95 expression on fetal and adult leukocytes
Expression of CD95 was analyzed by flow cytometry on leukocyte populations found in fetal (blood, spleen, liver and bone marrow) and adult (blood and bone marrow) tissues. The gestational ages of the fetal samples ranged from 15 to 24 weeks. CD95 was expressed on at least some cells of each of the lineages analyzed in both fetal and adult tissues.
Most circulating CD14
þ monocytes expressed CD95 at high levels ( Fig. 1) . In adult blood, a median 97.1% of monocytes expressed CD95. Likewise, a median 93.7% of fetal blood and 83.2% of fetal splenic monocytes showed CD95 expression ( Fig. 2A) . The levels of CD95 expressed on fetal and adult peripheral-blood monocytes also did not differ (Fig.  2B) , although the fetal splenic monocytes had reduced levels of CD95 ðP ¼ 0:053Þ: However, the reduced levels of CD95 in the spleen appeared to be the result of increased background staining, with non-specific isotype-matched control antibody, rather than reduced CD95 expression (data not shown). The expression of CD95 on the immature CD14 þ monocytes developing in hematopoietic tissues was also analyzed. Both in the fetal and adult bone-marrows, CD95 expression was apparent on cells expressing low and high levels of CD14 indicating that CD95 is already expressed at the time of CD14 acquisition (Fig. 3) . Few fetal CD15 þ granulocytes expressed CD95 (Fig. 1) . In adult blood, a median 86.0% of granulocytes expressed CD95, but only 22.0% of fetal blood and 21.1% of fetal splenic granulocytes expressed CD95 (Fig. 2A) . The decreased expression of CD95 in fetal tissues was significant compared to 
adult granulocytes ðP # 0:025Þ: The levels of CD95 expression on CD15 þ granulocytes was also significantly lower in the fetal spleen ðP ¼ 0:006Þ; but did not differ between fetal and adult blood (Fig. 2B ). CD95 expression appeared on those granulocytes with lower levels of CD15 expression as exemplified in Fig. 1 . Furthermore, immature granulocytes in the fetal and adult bone-marrows uniformly expressed CD95 (Fig. 3) . The immature CD95 þ CD15 low granulocytes were also enriched in the light-density fractions of fetal liver and neonatal UCB (data not shown), indicating that CD95 expression is a feature of young granulocytes that is decreased with maturation and increased CD15 expression.
The frequency of CD95 expression was decreased on CD19 þ B cells from fetal blood compared to adult blood ðP ¼ 0:005Þ ( Fig. 2A) . Although the level of CD95 expression was also decreased on fetal blood Bcells this difference was not significant (Fig. 2B) . CD95 expression on fetal splenic B-cells did not differ significantly from adult B-cells. The overall modest levels of CD95 expressed on peripheral B-cells were also observed on B cells in the fetal and adult bonemarrows (Fig. 3) . These results indicate a lack of CD95 expression on most immature B-cells and their immediate progenitors.
Both the frequency and levels of CD95 expression on CD56 þ CD3 2 NK-cells was comparable between fetal and adult cells (Fig. 1) . CD95 was expressed on a median 56.9 -79.8% of fetal and adult NK cells ( Fig. 2A) . Immature NK cells, expressing low levels of CD56, found in the fetal liver and adult bone marrow expressed CD95 (Fig. 3) . Thus, unlike the B cells, CD95 expression is a feature of maturing NK cells.
Expression of CD95 on fetal and adult T cells
A similar frequency of fetal and adult CD3 þ Tcells expressed CD95 (Figs. 1 and 2) . However, the levels of CD95 expression on fetal blood and splenic T-cells were less than half those on adult T-cells ðP # 0:003Þ (Fig. 2B) . In general, fetal T-cells consisted of a predominant population of cells that expressed low levels of CD95 and a small subpopulation of T cells that expressed higher levels of CD95 (Fig. 1) . Adult T-cells, in contrast, tended to be polarized into two subsets consisting of either CD95 þ or CD95 2 cells. The frequency and intensity of CD95 expressed by adult CD4 þ T cells were previously shown by Miyawaki et al. to be higher than for CD8 þ T cells [21] . Our analysis of adult T-cells confirmed these findings. On the contrary, analyses of fetal blood and splenic T-cells did not indicate any significant difference in the frequency of CD95 expression by CD4 þ and CD8 þ T-cells (data not shown). However, the intensity of CD95 expressed by fetal CD4 þ T-cells was modestly higher than by fetal CD8
þ T-cells. The signal to noise (S/N) ratio for CD95 expression was 28% and 68% higher for CD4 þ T-cells than for CD8 þ T-cells from blood and spleen, respectively (data not shown). These differences did not reach significance by paired analysis (P ¼ 0:071 for blood and 0.137 for Three-color analyses of CD3, CD4 and CD8 expression were performed on fetal blood and spleen samples ranging in age from 16 to 24 weeks' gestation. Although there were no significant differences in the ratio of CD4 to CD8 SP T-cells between fetal and adult samples, the younger fetal specimens had a lower ratio than older fetal specimens (data not shown). In three fetal samples younger than 19 weeks' gestation the CD4/CD8 ratio ranged from 0.46 to 1.8. In samples between 19 and 24 weeks had ratios that ranged from 2.0 to 2.7, comparable to ratios observed from adult blood.
The tendency towards higher CD95 expression on CD4 þ T-cells was also observed on SP T-cells in the fetal thymus (Fig. 4A) . Fetal thymi of 15, 19 and 22 weeks' gestation were analyzed and CD95 was found to be on 1.9-fold more CD4 SP thymocytes than on CD8 SP thymocytes (P ¼ 0:057; paired comparison). Low expression of CD95 was also observed on DP thymocytes. Double negative (DN) thymocytes were up to 83.5% CD95 þ ðn ¼ 3Þ: DN thymocytes include CD3 2 T-cell progenitors, CD3 þ immature T-cells and cells of various other lineages. Nonetheless, the majority of CD95 expression in the fetal thymus was on cells expressing high levels of CD3 as seen in Fig. 4B . To determine whether CD95 is expressed by T cells shortly before emigration from the thymus we analyzed CD3 þ CD45RA þ and CD3 þ CD45RO 2 thymocytes [29 -31] . There was CD95 expression on both of these overlapping subpopulations of thymocytes, indicating that CD95 is expressed at low levels on T cells that emerge from the thymus.
Expression of CD45 isoforms by fetal and adult T cells
The high frequency of CD95 expression on fetal T cells was unexpected considering published findings indicating low expression of this protein on neonatal T Previous findings have indicated a higher frequency of CD45RO þ CD45RA 2 T-cells in the fetus than the in the neonate [32] , thus possibly accounting for the higher rate of CD95 expression in the fetus. The CD45RO þ CD45RA 2 subset represented a median of 11.3% and 15.5% of T cells in the fetal blood and spleen, respectively, which was significantly higher than the median 1.5% in UCB obtained from full term newborns (P ¼ 0:031 for blood and , 0.001 for spleen) (Fig. 6A) . Although, the frequency of fetal CD45RO þ CD45RA 2 T-cells was reduced compared to the adult (P ¼ 0:046 for blood and 0.072 for spleen) (Fig. 6A) . Both fetal blood and spleen also had significantly reduced numbers of CD45RO þ CD45RA þ T-cells compared to adults, whereas CD45RO 2 CD45RA þ T-cells were more prevalent in the fetus than in the adult ðP # 0:028Þ (Fig. 6A ). The majority of T cells in UCB were 
whereas the CD45RO 2 CD45RA þ subpopulation was similarly represented in UCB compared to adult blood. Thus, the naive CD45RO 2 CD45RA þ T-cell subset is enriched in the fetus, but a notable number of CD45RO þ CD45RA 2 T-cells are present in the fetal circulation, more so than at the time of birth.
CD95 expression was detected on both CD45RA þ and CD45RO þ fetal T-cells, but differences between fetal and adult T cells were apparent (Figs. 5 and 6B ). The median frequency of fetal CD45RA þ T-cells that expressed CD95 was 62.0% in the blood and 85.4% in the spleen (Fig. 6B) . The median frequencies of CD95 expression on adult and neonatal CD45RA þ T-cells were significantly lower at 45.1% and 37.1%, respectively (P ¼ 0:012 for both comparisons). Most adult CD45RO þ T-cells expressed CD95 (median 89.1%), as previously described [21] . However, CD95 expression was reduced on CD45RO þ T-cells from fetal blood (median 59.7%), fetal spleen (median 72.8%) and UCB (median 54.9%). These differences in CD95 expression compared to adult CD45RO þ T-cells were significant ðP # 0:009Þ: Moreover, examination of the pattern of CD95 expression on fetal T-cells revealed a subpopulation of CD45RO þ CD45RA 2 T-cells that was Fig. 5, boxed regions) . These cells were best defined by their lack of CD45RA staining rather than their expression of CD45RO. This is because many CD45RO þ cells can also express CD45RA, whereas all CD45RA 2 cells are CD45RO
2 T-cell population was not present to any appreciable degree in either term UCB or adult peripheral blood.
Cytokine receptors and activation markers expression by fetal and adult T-cells
The expression of CD95 and CD45RO by fetal Tcells suggests the possibility that a sizable proportion of fetal T-cells have undergone activation. To support this hypothesis, we analyzed the expression of various cytokine receptors and other cell-surface markers associated with T-cell growth and activation ( Table 1) . Components of the IL-2 receptor complex were analyzed, which indicated that CD25 was expressed on a similar portion of fetal T-cells as on adult T-cells. In contrast, CD25 was significantly reduced on neonatal T-cells, particularly on the CD45RO þ subset. CD122 was expressed on a significantly higher number of fetal T-cells than on either neonatal or adult T-cells. The a-chain subunit of the IL-7 receptor, CD127, was widely expressed on T-cells from all sources, but was significantly reduced on the CD45RO þ subset of fetal T-cells. T cells in UCB expressed higher levels of CD127 compared to fetal or adult T-cells. CD132, the common g-chain subunit of the IL-2, IL-4, IL-7, IL-9 and IL-15 receptors, was Light-density cells isolated from fetal spleens and PBMC isolated from UCB and adult blood were analyzed for the expression of CD3, CD45RO and the indicated marker. 
expressed on nearly all T-cells at any stage of ontogeny. The markers CD69 and CD80 are expressed on T cells that have become activated [33 -35] . The frequency of fetal T-cells expressing these markers was higher than in the adult or neonate. CD56, which is expressed by a subpopulation of cytotoxic T-cells [36] , was expressed at similar levels in the fetus and adult, but was approximately half as abundant in the neonate. A significantly greater frequency of fetal T-cells were found to express g/d chains of the T-cell receptor.
Repertoire of TCR Vb chain expression by fetal T-cells and thymocytes
The TCR Vb chain repertoire expressed by fetal Tcells was studied to determine the diversity of TCR expression in the emerging immune system. Vb chain expression was analyzed on splenic CD3 þ cells ranging in age from 16 to 24 weeks' gestation (Fig. 7A) . A diverse repertoire was observed with the mean percent expression of each Vb chain falling within the range of expression observed on adult specimens, as reported by the manufacturer of the test reagents. Moreover, two subsets of fetal splenic Tcells, CD45RA 2 (CD45RO þ ) and CD45RA þ , were examined and both displayed diversity in Vb chain expression similar to as described above, except for the following differences: The CD45RA 2 subset had a higher representation of Vb11 (P , 0:05; n ¼ 3) and Vb5.1 ðP ¼ 0:075Þ and lower representation of Vb14, Vb16 and Vb21.3 (P , 0:05; n ¼ 3). The possibility that the CD45RA 2 T-cells in the spleen are thymocytes that have not gained CD45RA expression before exiting the thymus was examined by comparing the expression of Vb chains on splenic and thymic Fig. 7 . Expression of TCR Vb chains by fetal splenic T-cells and thymocytes. TCR Vb chain expression was analyzed by 4-color flow cytometry. T cells were identified by their expression of high levels of CD3 and by their low light scatter profile. Vb chain expression was analyzed from a cohort of 6 spleens ranging in gestation age from 16 to 24 weeks (A). Two of these spleens, of 19 and 22 weeks' gestation, were analyzed for Vb chain expression on T-cells subdivided based on the expression of CD45RA (B). Thymocytes from these same fetal specimens were also analyzed and were gated using the same region as used to define the corresponding splenic CD3 þ CD45RA 2 population. Results are presented as the mean^SE. (Fig. 7B) . Besides wideranging similarity and some non-significant dissimilarities, there were notable significant differences between the thymic and splenic T-cells. Mainly, a lower representation of Vb 1, Vb 3, Vb 5.2 and Vb 13.6 (P # 0:05; n ¼ 2) was observed on the splenic Tcells. These differences indicate that the splenic CD45RA 2 T-cells are not an exact match to the corresponding thymic population.
Discussion
The maturity of the human fetal immune system was analyzed from the perspective of CD95 expression as well as a number of additional cellsurface markers associated with T-cell activation and growth (Fig. 8) . Most knowledge regarding fetal Tcells has come from the analyses of neonatal T-cells obtained from UCB. Studies have shown neonatal Tcells to be comprised of primarily CD45RA þ naive/ resting T-cells [11 -15] that express low levels of the activation marker CD95 [21, 24] . In contrast, our examination of midgestation fetal tissues indicates that the frequency of T cells that express CD95 in these tissues is comparable to that of adult T-cells. However, the levels of CD95 expression are reduced on fetal T-cells. Although fetal T-cells were predominantly
þ CD45RA 2 T-cells were present in the blood of midgestation fetuses, more so than at full term. Furthermore, a number of cell-surface markers associated with T-cell activation, were also observed on fetal T-cells at levels similar or higher than in the adult. These data indicate a, heretofore, unappreciated level of activation of peripheral T-cells circulating in the immediate weeks following thymic development in the human fetus.
Byrne et al. have reported a higher frequency of CD45RO þ CD45RA 2 T-cells in the midgestation fetus compared to full-term neonates [32] . Our findings confirm this observation and extend them by describing a subset of CD45RO þ CD45RA 2 T-cells in the fetus that lacks CD95 expression (Fig. 8) . We are unaware of any previous description of a CD95 2 CD45RO þ CD45RA 2 subpopulation of T cells, and we did not observe this population in postnatal blood. Nearly all adult CD45RO þ CD45RA 2 Tcells are known to express CD95 at high levels [21] . Indeed, the higher frequency of CD45RO þ CD45RA
2 T-cells in adults is a contributing factor to the higher levels of CD95 expression observed on adult versus fetal T-cells. The role of the
T-cell subset in the developing immune system is presently unclear. The expression of CD45RO by these cells suggests that they may have been previously activated. Although there are some reports that suggest exposure of the fetus to external antigens can occur [37] , the prevalence of the CD45RO þ population of T cells could mean that these cells are being exposed to and subsequently responding to autologous antigens. We speculate that a developmentally early wave of activation of autoreactive T-cells may be an important step in the establishment of suppressor T-cell populations and peripheral tolerance. Indeed, the decreased expression of CD95 on these cells would be counter to the hypothetical removal of fetal autoreactive T-cells by a CD95-mediated apoptotic mechanism [32] . However, the loss of CD95 expression may still be associated with the removal 
of these cells since there is evidence that signaling through CD95 may support T-cell growth rather than apoptosis in some circumstances [38, 39] . A broader analysis of T-cell markers further supports our conclusion that the midgestation fetus contains a notable number of activated T-cells. Although a previous study failed to identify any CD56 þ natural cytotoxic T-cells in the fetus [40] , we observed a similar number of CD56 þ T-cells in the fetus as in the adult. About 17% of fetal T-cells expressed the g/d TCR which was higher than in the neonate and adult, consistent with previous findings [41] . CD69, an activation antigen expressed early in T-cell activation [33] , was expressed at nearly twice the frequency on fetal T-cells as on neonatal and adult T-cells. CD80 is a stimulatory molecule for T cells expressed by various leukocytes, which can be expressed on some T cells during the later phase of activation [34, 35] . CD80 was expressed on fetal Tcells, in particular CD45RO þ T cells, also at a higher frequency than in the neonate and adult. T-cell activation also results in upregulation of the a and b subunits of the IL-2 receptor, CD25 and CD122, respectively. Both components of the IL-2 receptor were found on fetal T-cells, with a notably higher number of CD122 þ T-cells in the fetus compared to the adult. Very little CD25 and CD122 expression was observed on neonatal T-cells. The expression of CD25 and CD122 by fetal T-cells suggests these cells may be activated, although it is possible that some of these cells represent CD4 þ suppressor/regulatory T-cells [42] . This regulatory subset of T cells has been described in UCB and is characterized in part by CD25 and CD122 expression [43] . IL-7 plays a critical role in the maintenance of the naïve T-cell pool through interaction with its receptor, CD127/ CD132 [44] . After T-cell activation, CD127 expression is lost and, as such, is another indication that T cells have been stimulated [45] . We observed CD127
2 T-cells in both the fetus as well as in the adult, although most T cells in both cases express CD127. Indeed, there was a higher portion of CD45RO þ T-cells that lacked CD127 expression in the fetus than in the adult. Moreover, CD127 was notably higher on neonatal T-cells compared to both fetal and adult T-cells. In total, these findings are consistent with a higher level of T-cell activation in the midgestation fetus than at term.
The abundant expression of CD95 by peripheral Tcells in the fetus prompted us to analyze the expression of CD95 on developing T-cells in the thymus (Fig. 8) . CD95 expression in the fetal thymus was predominantly found on T-cells that had already begun to express high levels of CD3, although the majority of DP and SP T-cells did not express CD95. Most DN thymocytes expressed CD95. Our findings are consistent with those of Jenkins et al. who observed CD95 expression on T-cell progenitors, but found very little expression on mature CD3
þ SP thymocytes. These investigators also demonstrated that the thymic cells are resistant to CD95-mediated apoptosis [25] . We wished to further elucidate the degree of CD95 expression on mature thymic T-cells set to enter the circulation. Most developing T-cells in the thymus express CD45RO, which is expressed in an inverse relationship to CD45RA. Before exiting the thymus, T cells are known to down-regulate CD45RO expression and become CD45RA þ [29 -31] . Examination of CD95 expression on thymic CD45RO
2 and CD45RA þ T-cells indicated that most T cells entering the periphery are CD95 þ , consistent with the expression of CD95 observed on peripheral CD45RA
þ T-cells. Since adult CD45RA þ T-cells, which are less likely to be recent thymic emigrants, expressed less CD95 it is likely that CD95 expression is reduced on naïve T-cells with time spent in the circulation.
There at least two additional potential explanations, besides (auto)antigen-specific activation, for the presence of T-cells in the fetal circulation with an activated phenotype. One possibility is that the markers associated with activation are expressed because of T-cell growth, associated with rapid expansion of the peripheral pool of T cells, rather than specific activation by antigen. Another possibility is that the CD45RO þ T-cells in the fetal circulation are recent thymic emigrants that emerged from the thymus before changing to the CD45RA þ phenotype. In attempt to distinguish these possibilities, the Vb chain repertoire was analyzed on fetal Tcells. A diverse repertoire, comparable to that of adults, was observed as early a 16 weeks gestation. It is worth mention that methods more sensitive to minor sequence differences have shown reduced diversity within the Vb chain families of late-gestation fetal and some neonatal blood samples [46, 47] Our results also demonstrated diversity within the CD45RA 2 (CD45RO þ ) subset of fetal T-cells indicating that this subset is not derived from the activation and expansion of one or a few T-cell clones. Differences in Vb chain expression between splenic and thymic CD45RA
2 T-cells suggest that the splenic cells are not recent emigrants from the thymus, although further experiments are required to bolster this conclusion. There were also some differences in Vb chain expression between splenic CD45RA
2 and CD45RA þ T-cells, which may indicate selective expansion of T cell clones. However, further study is required to distinguish the possible reasons for the expression of activation markers on fetal T-cells.
We further examined if CD95 expression can be viewed as a marker of activation or maturation for leukocyte lineages other than T-cells (Fig. 8) . CD95 was expressed on immature cells of all lineages and was down-regulated with maturation, except in the case of monocytes which expressed CD95 even in the sterile fetal environment. In contrast, granulocytes reduced their expression of CD95 after entering the circulation. Likewise, CD95 expression was decreased or lost on NK cells in the circulation, possibly due to a lack of growth or activation stimulus, although increased CD95 expression is correlated with in vitro activation of NK cells [48, 49] . B cells expressed less CD95 than most other lineages during their development in the fetal or adult bone-marrow. Most CD19 þ and CD10 þ cells in hematopoietic tissues did not express CD95 and expression on circulating fetal B-cells was low and decreased compared to the adult. Miyawaki et al. first described similar results for UCB and adult peripheral blood B-cells [21] . CD95 expression on B cells correlates with increased functional differentiation and is, thus, likely low on fetal B-cells owing to their lack of stimulation and hormonal suppression. These findings show a diverse and variable expression of CD95 in the development of hematopoietic cells, indicating that CD95 expression alone is not a reliable marker of maturational status or activation.
Continued research into the development and functional status of the human fetal immune system should lead to new insights into the steps required in the development of the immune system and the establishment of peripheral tolerance towards autologous antigens. These insights may lead to better therapies for immune compromised patients and transplant patients. Efforts at fetal gene or cellular therapy would also benefit greatly from a clearer understanding of the functional capacity of the immune system at various stages of development.
